Eric H. Bjerkholt
2015 - Sunesis Pharmaceuticals
In 2015, Eric H. Bjerkholt earned a total compensation of $869.7K as Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary at Sunesis Pharmaceuticals, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,000 |
|---|---|
| Option Awards | $305,881 |
| Salary | $410,500 |
| Other | $4,306 |
| Total | $869,687 |
Bjerkholt received $410.5K in salary, accounting for 47% of the total pay in 2015.
Bjerkholt also received $149K in non-equity incentive plan, $305.9K in option awards and $4.3K in other compensation.
Rankings
In 2015, Eric H. Bjerkholt's compensation ranked 8,599th out of 13,638 executives tracked by ExecPay. In other words, Bjerkholt earned more than 36.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,599 out of 13,638 | 37th |
Division Manufacturing | 3,282 out of 5,187 | 37th |
Major group Chemicals And Allied Products | 1,192 out of 1,857 | 36th |
Industry group Drugs | 968 out of 1,531 | 37th |
Industry Pharmaceutical Preparations | 756 out of 1,179 | 36th |
Source: SEC filing on April 20, 2017.
Bjerkholt's colleagues
We found one more compensation record of an executive who worked with Eric H. Bjerkholt at Sunesis Pharmaceuticals in 2015.
2015
Daniel Swisher
Sunesis Pharmaceuticals